Atrial Flutter


Table of Contents

  1. Overview
  2. Epidemiology
  3. Classification (Typical vs Atypical Flutter)
  4. Pathophysiology (Cavotricuspid Isthmus Reentry)
  5. Clinical Presentation
  6. Diagnosis and ECG Features
  7. Rate Control
  8. Cardioversion and Anticoagulation
  9. Catheter Ablation (CTI Ablation)
  10. Thromboembolic Risk and Prevention
  11. Research Papers
  12. Connections
  13. Featured Videos

Back to Table of Contents

1. Overview

Atrial flutter (AFL) is a macro-reentrant atrial arrhythmia characterized by rapid, organized atrial electrical activity at approximately 250–350 beats per minute, most commonly around 300 bpm. Unlike atrial fibrillation with its chaotic, disorganized activity, atrial flutter maintains a regular, organized circuit — producing the distinctive "sawtooth" flutter wave pattern on ECG.

Typical atrial flutter (type I, common flutter) is the most prevalent form, driven by a counterclockwise reentrant circuit in the right atrium dependent on the cavotricuspid isthmus (CTI) — a narrow corridor of myocardium between the inferior vena cava and the tricuspid annulus. This CTI-dependent nature makes typical flutter exquisitely amenable to catheter ablation, with cure rates exceeding 95%.

AFL occupies a distinct but interrelated position with atrial fibrillation on the arrhythmia spectrum: the two conditions frequently coexist, share common risk factors, and carry similar thromboembolic risk. Approximately 50–80% of atrial flutter patients will develop AF over time.


Back to Table of Contents

2. Epidemiology

Atrial flutter has an estimated prevalence of 200,000 in the United States, with an annual incidence of approximately 88 per 100,000 person-years. Incidence increases sharply with age: the annual incidence in those over 80 approaches 587 per 100,000. Men are affected 2.5 times more frequently than women.

Risk factors parallel those of AF: age, hypertension, coronary artery disease, heart failure, obesity, diabetes, chronic obstructive pulmonary disease, obstructive sleep apnea, and excessive alcohol consumption. AFL is particularly prevalent post-cardiac surgery (25–35% of patients) and after pulmonary vein isolation procedures for AF, where scar tissue can create new reentrant circuits (incisional flutter).


Back to Table of Contents

3. Classification

Typical AFL (Type I, CTI-dependent, counterclockwise): The dominant form (>90% of AFL). The circuit rotates counterclockwise in the right atrium (as viewed in left anterior oblique fluoroscopic projection): ascending the right atrial septum (interatrial septum), across the roof, descending the right atrial free wall (crista terminalis acts as a functional posterior barrier), and pivoting around the tricuspid annulus isthmus (CTI). ECG shows negative sawtooth F waves in inferior leads (II, III, aVF) and positive F waves in V1.

Clockwise (reverse typical) AFL: Same CTI-dependent circuit but rotating clockwise — producing positive flutter waves in inferior leads and negative in V1. Less common (~10% of typical AFL).

Atypical AFL (Type II, non-CTI-dependent): Reentrant circuits not dependent on the CTI. Includes: perimitral flutter (circuit around mitral annulus), roof-dependent flutter, left atrial flutter, incisional flutter (scar-dependent after cardiac surgery or ablation). Typically requires advanced electroanatomical mapping for characterization.


Back to Table of Contents

4. Pathophysiology (Cavotricuspid Isthmus Reentry)

The cavotricuspid isthmus forms the critical bridge in typical AFL. It is bounded anteriorly by the tricuspid annulus (electrically inexcitable) and posteriorly by the inferior vena cava (inexcitable). The isthmus is typically 20–40 mm wide and 30–50 mm long, with slow and non-homogeneous conduction properties that allow the reentrant circuit to sustain.

The crista terminalis serves as a line of functional block along the posterior right atrial wall, preventing short-circuiting of the circuit and forcing the wavefront to travel the full path around the tricuspid annulus.

At 300 bpm atrial rate, the AV node typically conducts every other flutter wave — producing 2:1 AV block and a ventricular rate of approximately 150 bpm. This ventricular rate of 150 bpm is a highly specific clinical finding for flutter and should trigger immediate suspicion. 4:1 block (ventricular rate ~75 bpm) occurs spontaneously or after rate-control drugs. Variable AV block can produce an irregular ventricular response.

AFL-AFib continuum: Both arrhythmias share pathophysiologic substrates (atrial fibrosis, stretch, inflammation). Pulmonary vein triggers can initiate AF; the organized CTI circuit sustains flutter. AFL can degenerate into AF and vice versa, particularly after pharmacologic cardioversion where flutter may slow sufficiently to permit AFib triggers.


Back to Table of Contents

5. Clinical Presentation

Clinical features are similar to AFib but with important distinctions:

AFL may present asymptomatically (discovered incidentally) or with hemodynamic instability (particularly in patients with structural heart disease or when ventricular rates are very rapid: 1:1 conduction with rates of 300 bpm can occur with class IC drugs like flecainide that slow atrial rate but paradoxically enable 1:1 conduction — medical emergency).

Carotid sinus massage or adenosine can transiently increase AV block (2:1 → 4:1 → 8:1), dramatically slowing the ventricular rate and unmasking the sawtooth flutter waves — an important diagnostic maneuver.


Back to Table of Contents

6. Diagnosis and ECG Features

The 12-lead ECG is diagnostic:

Carotid massage/adenosine transiently blocks AV conduction, increasing block ratio and making F waves clearly visible.

Differential Diagnosis


Back to Table of Contents

7. Rate Control

Rate control in AFL is often more difficult to achieve than in AFib because the regular organized flutter circuit is less susceptible to drug-induced disruption of conduction. Medications that slow AV nodal conduction may be needed in high doses:

Warning — Class IC drugs (flecainide, propafenone) alone: These drugs slow the flutter rate from ~300 to ~200 bpm without blocking the AV node — potentially enabling 1:1 AV conduction at 200 bpm, causing extreme tachycardia and hemodynamic collapse. Always co-administer AV nodal blocking drugs if Class IC agents are used.


Back to Table of Contents

8. Cardioversion and Anticoagulation

Electrical cardioversion: Atrial flutter is highly responsive to DC cardioversion. Low energy shocks (50–100 J biphasic) achieve cardioversion in >95% of cases — AFL requires less energy than AF. Synchronized mode is essential.

Pharmacologic cardioversion: Ibutilide (class III, 1 mg IV over 10 minutes, repeat once) converts flutter in ~60% of cases; risk of torsades de pointes requires monitored setting with QTc correction pre-treatment. Dofetilide is an alternative. Amiodarone has limited efficacy for acute AFL termination.

Anticoagulation per AFib guidelines: The thromboembolic risk of AFL is equivalent to AF. The same anticoagulation strategy applies:


Back to Table of Contents

9. Catheter Ablation (CTI Ablation)

CTI ablation is the preferred long-term therapy for typical AFL, with success rates exceeding 95% and very low recurrence rates (~5–10%):


Back to Table of Contents

10. Thromboembolic Risk and Prevention

AFL carries thromboembolic risk equivalent to AF despite the organized atrial activity. Pathophysiologic explanation: although atrial contractile function appears to be maintained in AFL, atrial mechanical dysfunction can persist (atrial "stunning") after cardioversion, and left atrial appendage (LAA) flow is frequently impaired during AFL.

Embolic risk from AFL is substantial:

Anticoagulation should be initiated and maintained even after successful CTI ablation if the patient's CHA₂DS₂-VASc score warrants it, due to high AF conversion risk.


Back to Table of Contents

Research Papers

The following PubMed topic searches return current peer-reviewed literature relevant to this condition. Each link opens a live PubMed query.

Back to Table of Contents


Connections

Back to Table of Contents